IMEXHS Limited signed a new contract with IMSS

IMEXHS Limited (ASX: IME) announced that its local partner Ingenieria para el Cuidado de la Salud, S.A., had been selected as its preferred bidder for the IMSS RIS/PACS tender for two hospitals for three years. This contract will be worth between US$700,000 and $900,000 and contribute between US$230,000 and $300,000 in Annual Recurring Revenue (ARR).

Under the contract, the company’s partner will implement AQUILA (the radiology platform) and ALULA (the pathology platform). The software is expected to go live in the first quarter of 2023. The IMSS is Mexico’s public healthcare system that covers 80 million people and carries out over 420,000 medical consultations daily. The IMEXHS was selected due to its excellent service across Mexico for more than 4-years and the company’s ability to provide radiology and pathology systems.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com